Patents by Inventor Markus KRUEER

Markus KRUEER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20230270829
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: November 10, 2022
    Publication date: August 31, 2023
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRUEER, Nico WEGENER
  • Use of botulinum neurotoxin in the treatment of sialorrhea
    Patent number: 11529398
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: December 20, 2022
    Assignee: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krueer, Nico Wegener
  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20200297823
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 24, 2020
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRUEER, Nico WEGENER
  • Use of botulinum neurotoxin in the treatment of sialorrhea
    Patent number: 10709772
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: July 14, 2020
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Janos Csikos, Irena Pulte, Michael Althaus, Markus Krüer, Nico Wegener
  • USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA
    Publication number: 20190000938
    Abstract: This invention relates to improved uses of botulinum neurotoxins in the treatment of sialorrhea or diseases or conditions relating to increased saliva production. In particular are botulinum neurotoxins disclosed which are administered into parotid and submandibular glands in a dose ratio between 1.45 to 1 and 1.7 to 1.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 3, 2019
    Inventors: Janos CSIKOS, Irena PULTE, Michael ALTHAUS, Markus KRÜER, Nico WEGENER